$6.89
+0.17 (+2.53%)
Open$6.59
Previous Close$6.72
Day High$7.28
Day Low$6.50
52W High$80.10
52W Low$2.98
Volume—
Avg Volume906.9K
Market Cap3.85M
P/E Ratio—
EPS$-461.25
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 11.79M | 13.72M | 1.35M |
| Net Income | -167,715,984 | -175,700,600 | 424.2K |
| Profit Margin | -1,422.8% | -1,351.6% | 31.3% |
| EBITDA | -112,095,238 | -123,955,856 | 830.6K |
| Free Cash Flow | — | — | 355.4K |
| Rev Growth | -14.1% | -14.1% | -3.8% |
| Debt/Equity | 0.08 | 0.08 | 1.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |